Biogen Newsroom

Biogen Analyst Ratings

BenzingaDec 10 20:41

B of A Securities Reinstates Neutral on Biogen, Announces $178 Price Target

BenzingaDec 10 20:39

Biogen Analyst Ratings

BenzingaDec 9 19:42

Jefferies Downgrades Biogen(BIIB.US) to Hold Rating, Cuts Target Price to $180

Futu NewsDec 9 19:31

Biogen's Modest Growth Prospects and Revenue Challenges Highlighted in Hold Rating

TipRanksDec 9 18:40

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Biogen (BIIB) and Edwards Lifesciences (EW)

TipRanksDec 6 02:14

Morgan Stanley Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $192

Futu NewsDec 6 01:35

RBC Capital Sticks to Its Buy Rating for Biogen (BIIB)

TipRanksNov 28 09:49

Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250

Futu NewsNov 25 23:30

Jefferies Remains a Buy on Biogen (BIIB)

TipRanksNov 25 23:27

Biogen Is Maintained at Outperform by Mizuho

Dow JonesNov 21 21:19

Biogen Analyst Ratings

BenzingaNov 21 21:09

Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $207

Futu NewsNov 21 20:32

Mizuho Securities Adjusts Price Target on Biogen to $207 From $251

MT NewswiresNov 20 23:14

Biogen Price Target Maintained With a $270.00/Share by Needham

Dow JonesNov 18 18:19

Biogen Analyst Ratings

BenzingaNov 18 18:09

TD Cowen Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $275

Futu NewsNov 15 21:33

Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $250

Futu NewsNov 15 21:31

A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $204 to $300

Futu NewsNov 15 21:03

Biogen (BIIB) Gets a Buy From TD Cowen

TipRanksNov 15 21:00